Amgen warrants that Amgen has validly entered into these Terms and has the legal power to do so. You warrant that you have validly entered into these Terms and have the legal power to do so.EXCEPT AS EXPRESSLY PROVIDED ABOVE, THE SERVICES ARE PROVIDED "AS IS" AND "AS AVAILABLE" WITHOUT...
We have constructed this website so that you may visit the site and review information about the services we offer without revealing your identity or volunteering any personally identifying information. If you register to use the website's features and services, we will collect "personally ...
Aug 24, 2024KRASG12C Inhibitors in Non-Small Cell Lung Cancer: A Review Learn more by requesting a demo Amgen Investments 11 Investments Amgen has made 11 investments. Their latest investment was in Quantinuum as part of their Series A on January 04, 2024. Amgen Investments Activity View In...
Our Phase 1 and Phase 2 data are based on protocol specified intent to treat criteria as is our practice and the scans to assess efficacy parameters in Phase 2 have been evaluated by Independent Central Review. We look forward to presenting the Phase 2 results at the World Congress on Lung ...
Regularly review internal and external training resources to stay current on best practices and methodologies for training/learning Partner with other trainers and supervisors to provide updates and support project management of learning programs Support performance assessment and mentor including new hire man...